Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.
Authors:
- Toshihiro FukushimaTFToshihiro Fukushima
- Hiroshi KawabataHKHiroshi Kawabata
- Toshioki SawakiTSToshioki Sawaki
- Tomomi SatohTSTomomi Satoh
- Takuji NakamuraTNTakuji Nakamura
- Haruka IwaoHIHaruka Iwao
- Akio NakajimaANAkio Nakajima
- Tomoyuki SakaiTSTomoyuki Sakai
- Miyuki MikiMMMiyuki Miki
- Yoshimasa FujitaYFYoshimasa Fujita
- Masao TanakaMTMasao Tanaka
- Takafumi KawanamiTKTakafumi Kawanami
- 1 April 2012
- journal article
- Vol. 32 (4) , 1347-53